Marrero JA - Search Results

1

Mailed Outreach Program Increases Ultrasound Screening of Patients With Cirrhosis for Hepatocellular Carcinoma.

Singal AG, Tiro JA, Marrero JA, McCallister K, Mejias C, Adamson B, Bishop WP, Santini NO, Halm EA. Singal AG, et al. Among authors: marrero ja. Gastroenterology. 2017 Feb;152(3):608-615.e4. doi: 10.1053/j.gastro.2016.10.042. Epub 2016 Nov 5. Gastroenterology. 2017. PMID: 27825963 Free PMC article. Clinical Trial.

2

Hepatocellular carcinoma.

Marrero JA. Marrero JA. Curr Opin Gastroenterol. 2005 May;21(3):308-12. doi: 10.1097/01.mog.0000159817.55661.ca. Curr Opin Gastroenterol. 2005. PMID: 15818151 Review.

3

Diagnosis and treatment of hepatocellular carcinoma.

El-Serag HB, Marrero JA, Rudolph L, Reddy KR. El-Serag HB, et al. Among authors: marrero ja. Gastroenterology. 2008 May;134(6):1752-63. doi: 10.1053/j.gastro.2008.02.090. Gastroenterology. 2008. PMID: 18471552 Review.

4

Role of liver transplantation in the treatment of cholangiocarcinoma.

Singal A, Welling TH, Marrero JA. Singal A, et al. Among authors: marrero ja. Expert Rev Anticancer Ther. 2009 Apr;9(4):491-502. doi: 10.1586/era.09.5. Expert Rev Anticancer Ther. 2009. PMID: 19374602 Review.

5

Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis.

Singal A, Volk ML, Waljee A, Salgia R, Higgins P, Rogers MA, Marrero JA. Singal A, et al. Among authors: marrero ja. Aliment Pharmacol Ther. 2009 Jul;30(1):37-47. doi: 10.1111/j.1365-2036.2009.04014.x. Epub 2009 Apr 8. Aliment Pharmacol Ther. 2009. PMID: 19392863 Free PMC article.

6

The clinical presentation and prognostic factors for intrahepatic and extrahepatic cholangiocarcinoma in a tertiary care centre.

Singal AG, Rakoski MO, Salgia R, Pelletier S, Welling TH, Fontana RJ, Lok AS, Marrero JA. Singal AG, et al. Among authors: marrero ja. Aliment Pharmacol Ther. 2010 Mar;31(6):625-33. doi: 10.1111/j.1365-2036.2009.04218.x. Epub 2009 Dec 10. Aliment Pharmacol Ther. 2010. PMID: 20003093 Free article.

7

Recent advances in the treatment of hepatocellular carcinoma.

Singal AG, Marrero JA. Singal AG, et al. Among authors: marrero ja. Curr Opin Gastroenterol. 2010 May;26(3):189-95. doi: 10.1097/MOG.0b013e3283383ca5. Curr Opin Gastroenterol. 2010. PMID: 20224395 Review.

8

Patient involvement in healthcare is associated with higher rates of surveillance for hepatocellular carcinoma.

Singal AG, Volk ML, Rakoski MO, Fu S, Su GL, McCurdy H, Marrero JA. Singal AG, et al. Among authors: marrero ja. J Clin Gastroenterol. 2011 Sep;45(8):727-32. doi: 10.1097/MCG.0b013e31820989d3. J Clin Gastroenterol. 2011. PMID: 21602704

9

Interferon therapy and prevention of hepatocellular carcinoma in hepatitis C.

Singal AG, Marrero JA. Singal AG, et al. Among authors: marrero ja. Dig Dis Sci. 2012 Apr;57(4):832-4. doi: 10.1007/s10620-012-2069-8. Epub 2012 Feb 22. Dig Dis Sci. 2012. PMID: 22354544 No abstract available.

10

Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis.

Singal AG, Conjeevaram HS, Volk ML, Fu S, Fontana RJ, Askari F, Su GL, Lok AS, Marrero JA. Singal AG, et al. Among authors: marrero ja. Cancer Epidemiol Biomarkers Prev. 2012 May;21(5):793-9. doi: 10.1158/1055-9965.EPI-11-1005. Epub 2012 Feb 28. Cancer Epidemiol Biomarkers Prev. 2012. PMID: 22374994 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

203 results

Search Page